Skip to main content
. 2009 Nov 16;6:104. doi: 10.1186/1742-4690-6-104

Figure 4.

Figure 4

Seroreactivity to HERV-H Env and HERV-W Env derived peptides in patients with active MS (AMS), stable MS patients (SMS), and healthy individuals (HC) and neurological non-inflammatory controls (NC). The horizontal lines indicate median TRIFMA ratios for each group. Significant differences (P ≤ 0.05) between the groups are shown.